ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 944

$448K Total Retail Price of All Prescriptions

Rank: 268 out of 944

368 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,130 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 397 318 1 2
SIMVASTATIN 359 310 2 1
AMLODIPINE BESYLATE 319 251 3 5
LISINOPRIL 238 193 4 3
OMEPRAZOLE 223 173 5 4
ATORVASTATIN CALCIUM 213 167 6 13
CARVEDILOL 192 164 7 30
HYDROCODONE-ACETAMINOPHEN 191 134 S3 8 10
FUROSEMIDE 177 131 9 6
LOSARTAN POTASSIUM 174 117 10 16
HYDROCHLOROTHIAZIDE 166 149 11 9
POTASSIUM CHLORIDE 143 110 12 15
METOPROLOL SUCCINATE 142 110 13 14
METFORMIN HCL ER 134 109 14 49
WARFARIN SODIUM 128 104 15 7
FENOFIBRATE 117 86 16 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 100 17 29
ALLOPURINOL 113 108 18 22
SERTRALINE HCL 108 76 19 23
GABAPENTIN 106 64 20 18
ZOLPIDEM TARTRATE 100 70 21 25
METOPROLOL TARTRATE 97 87 22 8
LOSARTAN-HYDROCHLOROTHIAZIDE 91 84 23 54
MELOXICAM 90 64 24 68
ALENDRONATE SODIUM 88 88 25 20
PRAVASTATIN SODIUM 87 84 26 17
PANTOPRAZOLE SODIUM 78 68 27 34
ATENOLOL 73 67 28 11
FLUTICASONE PROPIONATE 66 37 29 40
CRESTOR 65 55 30 28
SPIRIVA 63 55 31 65
METFORMIN HCL 63 56 31 12
FLUOXETINE HCL 62 45 33 48
ENALAPRIL MALEATE 59 54 34 43
PREDNISONE 58 43 35 32
TRAMADOL HCL 58 37 35 21
DONEPEZIL HCL 57 57 37 24
CITALOPRAM HBR 54 44 38 19
DICLOFENAC SODIUM 53 30 39 106
ADVAIR DISKUS 53 38 39 31
BACLOFEN 52 28 41 111
DIOVAN 51 48 42 38
BYSTOLIC 51 51 42 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.